Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CUPRIC vs CYCLOBENZAPRINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CUPRIC vs CYCLOBENZAPRINE: Safety Overview

Metric CUPRIC CYCLOBENZAPRINE
Total FAERS Reports 376 9,148
Deaths Reported 5 3,862
Death Rate 1.3% 42.2%
Hospitalizations 127 2,820
Average Patient Age 68.2 yrs 58.8 yrs
% Female Patients 96.4% 83.2%
FDA Approval Date Apr 30, 2024 Approved Prior to Jan 1, 1982
Manufacturer American Regent, Inc. REMEDYREPACK INC.
Route INTRAVENOUS ORAL
Marketing Status Prescription Discontinued